Analysts expect over 2018 rising revenue Johnson & Johnson

Tomorrow the American Johnson & Johnson will publish its past quarter's figures. Over the current book year the total revenue will be 81,13 billion USD (consensus estimates). This is slightly more than 2016's revenue of 76,45 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

The analysts expect for 2018 a net profit of 22,08 billion USD. According to most of the analysts the company will have a profit per share for this book year of 8,1 USD. The price/earnings-ratio is then 16,13.

For this year the analysts expect a dividend of 3,58 USD per share. The dividend yield is then 2,74 percent. The average dividend yield of the health care companies equals a limited 1 percent.

Newest target prices around 160 USD

Morgan Stanley , Jefferies & Co. and Leerink Swann & Company recently provided recommendations for the stock.

Based on the current number of outstanding shares Johnson & Johnson 's market capitalization is 353,52 billion USD.

On Thursday the stock closed at 130,62 USD.

Historical stock prices Johnson & Johnson

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.